Memory loss is not necessarily a normal part of aging. What do recent Alzheimer's Disease trials really mean for patients and families?

In this episode of The CortiCare Podcast, Bradley Beauchamp, BS, R. EEG T, CLTM, sits down with Dr. Katherine Coerver to break down the latest research surrounding GLP-1 medications, anti-amyloid therapies, and where treatment innovation may be headed next.

They discuss:

• Why GLP-1 drugs created excitement in Alzheimer’s research

• What recent clinical trials actually showed

• FDA-approved therapies available today

• Why early evaluation matters

• Healthy brain habits everyone should start now

Chapters:

00:00 Intro

00:33 GLP-1 Studies

03:45 GLP-1 Results

07:09 Anti-Amyloid Trials

08:44 Anti-Amyloid Results

11:33 Comparison ...